Dr. Daniel Joseph Lachant, DO

Dr. Lachant practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Lachant's NPI, 1558650713, was assigned on March 28, 2011. Dr. Lachant graduated from Philadelphia College of Osteopathic Medicine in 2011. Dr. Lachant holds New York license 267624.

Dr. Lachant's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Lachant's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Lachant to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lachant practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Lachant's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Lachant is licensed in New York.

CMS data shows 85 Medicare services from Dr. Lachant across 2 procedure codes in 2024, for 51 Medicare patients. Medicare paid $4,050 for them. Every service was in an office.

CMS counts 51 Medicare patients who saw Dr. Lachant in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have heart failure, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lachant's median patient age at 70, with 63% women.

In 2024, Dr. Lachant wrote 1,943 Medicare Part D claims for 145 patients. 78% of them were for generic drugs. CMS names the drug for 1,845 of them, across 15 drugs with 11 or more claims each, at $10,679,277 in total drug cost. In 2023, CMS named 2,304 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lachant for performance year 2024, reported as part of a group. Dr. Lachant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lachant as offering telehealth.

Dmand AI links 37 papers to Dr. Lachant, published from 2013 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Anticoagulants. Dr. Lachant has published most often in Pulm Circ. Dr. Lachant's most frequent co-authors are Paritosh Prasad, MD, Christina Thanh Bach, MD and Daniel Patrick Croft, MD.

Dmand AI links Dr. Lachant to 3 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Familial Primary Pulmonary Hypertension. United Therapeutics sponsors the most, 2.

CMS Open Payments shows 185 general payments to Dr. Lachant from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. United Therapeutics Corporation paid the most, $61,494. It also lists 13 research payments totaling $3,166 in 2024.

Dr. Lachant graduated from Philadelphia College of Osteopathic Medicine in 2011.